Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood?

scientific article published on 10 February 2011

Current controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/PD.2681
P698PubMed publication ID21374636
P5875ResearchGate publication ID50273059

P50authorBeryl R BenacerrafQ89950977
P2093author name stringSimcha Yagel
Jan M M van Lith
P2860cites workNoninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical ConsiderationsQ58029492
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal bloodQ24657306
Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal PlasmaQ28314918
Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statisticsQ28752377
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detectionQ33268343
Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidyQ33980278
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.Q34385131
Rapid clearance of fetal DNA from maternal plasmaQ34388637
First- and second-trimester evaluation of risk for Down syndromeQ34643774
Role of second-trimester genetic sonography after Down syndrome screeningQ36776424
Time to reconsider our approach to echogenic intracardiac focus and choroid plexus cystsQ37119113
Impact of first-trimester aneuploidy screening in a high-risk populationQ37611397
Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.Q39904859
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21.Q39906674
Contingent screening for Down syndrome--results from the FaSTER trial.Q46781339
First-trimester or second-trimester screening, or both, for Down's syndromeQ46799629
Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencingQ47427812
Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21.Q53063252
Presence of fetal DNA in maternal plasma and serumQ57075132
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationQ57523616
P433issue3
P921main subjectDown syndromeQ47715
P304page(s)231-234
P577publication date2011-02-10
P1433published inPrenatal DiagnosisQ15760059
P1476titleCurrent controversies in prenatal diagnosis 2: Down syndrome screening: is ultrasound better than cell-free nucleic acids in maternal blood?
P478volume31

Reverse relations

cites work (P2860)
Q27003962Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma
Q37991200Imaging clues in the prenatal diagnosis of syndromes and aneuploidy

Search more.